{
    "Trade/Device Name(s)": [
        "Deepblue Multi-Drug Urine Test Cup",
        "Deepblue Home Muti-Drug Urine Test Cup"
    ],
    "Submitter Information": "ANHUI Deepblue Medical Technological Co., Ltd.",
    "510(k) Number": "K250803",
    "Predicate Device Reference 510(k) Number(s)": [
        "K240686"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGL",
        "PTH",
        "NFT",
        "NFV",
        "NFY",
        "PTG",
        "NGG",
        "NGM",
        "QBF",
        "QAW",
        "NFW"
    ],
    "Summary Letter Date": "March 16, 2025",
    "Summary Letter Received Date": "March 17, 2025",
    "Submission Date": "March 9, 2025",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3700",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Opiate Test System",
        "Benzodiazepine Test System",
        "Cocaine and cocainemetabolite Test System",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Propoxyphene Test System",
        "Tricyclic Antidepressant Drugs Test System",
        "Cannabinoids Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "6-Monoacetylmorphine",
        "Amphetamine",
        "Secobarbital",
        "Buprenorphine",
        "Oxazepam",
        "Benzoylecgonine",
        "EDDP",
        "Fentanyl",
        "Methylenedioxymethamphetamine",
        "Methamphetamine",
        "Methadone",
        "Morphine",
        "Oxycodone",
        "Phencyclidine",
        "Propoxyphene",
        "Nortriptyline",
        "THC-COOH",
        "Cocaine",
        "Marijuana",
        "Ecstasy"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Deepblue Multi-Drug Urine Test Cup",
        "Deepblue Home Muti-Drug Urine Test Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Competitive binding",
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative drug screening",
        "Lateral flow immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Specimen collection device",
        "Detection system",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for Deepblue Multi-Drug Urine Test Cup and Deepblue Home Muti-Drug Urine Test Cup for rapid qualitative detection of drugs of abuse in human urine using lateral flow immunoassay.",
    "Indications for Use Summary": "Rapid lateral flow immunoassay for qualitative detection of drugs of abuse in human urine, providing preliminary results for up to 17 analytes including amphetamines, opiates, barbiturates, benzodiazepines, cocaine, methadone, marijuana, fentanyl, and others.",
    "fda_folder": "Toxicology"
}